跳至主要内容
临床试验/CTRI/2025/01/079772
CTRI/2025/01/079772尚未招募不适用

A Comparative Clinical study to evaluate the efficacy of Viparithalajjalu Ksheerapaka and Ashoka Ksheerapaka in Asrigdara

DrJinsekharS1 个研究点 分布在 1 个国家目标入组 228 人开始时间: 2025年3月17日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
228
试验地点
1
主要终点
To evaluate and compare the efficacy of Viparithalajjalu ksheerapaka and Ashoka Ksheerapaka in the management of Asrigdara.

研究概览

简要总结

A COMPARATIVE CLINICAL STUDY TO EVALUATE THE EFFICACY OF VIPARITHALAJJALU KSHEERAPAKA AND ASHOKA KSHEERAPAKA IN ASRIGDARA

NEED FOR THE STUDY

Abnormal uterine bleeding is a common but complicated clinical presentation. it included both dysfunctional uterine bleeding and bleeding due to structural causes. Arigdara is an excessive or prolonged flow of blood occurring in the menstrual or intermenstrual period as per manuscripts of Ayurveda .it shows a close resemblance to AUB and DUB. So many oral preparations are found effective in clinical practices but effectiveness is not proven statistically. Acharyas have mentioned that the treatment of rakhathapithahara can be adopted in asrigdara . the drug of viparithalajjalau  ksheerpaka has the property of rakhathapithahara .in yogamritham Asrigdara chapter,sidhaprayoga mentioned about viparithalaljjalu prayoga,clinically found effective and statically not proven , the present study was undertaken to analyze statically.

MATERIALS AND METHOD

A separate case proforma will be prepared with history-taking, physical signs and symptoms, lab investigation, and USG findings mentioned by allied sciences. The parameters of signs symptoms and investigation will be scored based on standard methods and will be assessed statistically.

Designs of study: A single-blind clinical study of two groups of control and trials consisting of 114 subjects.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
20.00 Year(s) 至 40.00 Year(s)(—)
性别
Female

入选标准

  • Cardinal symptoms of Asrigdara with a minimum of 2 months history.
  • Patients with the age group of 20 years to 40years.
  • The number of pads used daily decides the quantity of menstrual blood.
  • The pads used during the period were of the same company.
  • PCOD (prolonged bleeding and excessive bleeding).
  • Patients having Hb% above 7gm/dL.

排除标准

  • bleeding due to benign and malignant growth coagulation disorders bleeding from the site other than the uterus lactation period patients having Hb% below 7gm/dl.

结局指标

主要结局

To evaluate and compare the efficacy of Viparithalajjalu ksheerapaka and Ashoka Ksheerapaka in the management of Asrigdara.

时间窗: both the groups will be administered with ksheerapa 40 ml twice daily before food for 3 cycles for excessive bleeding from 2nd day to 5 continuous days and prolonged bleeding starting from 4 the day of menstruation to 5 continuous days

次要结局

  • To study the property and effect of viparithalajjalu ksheerapaka and Ashoka ksheerapaka in Asrigdara

研究者

发起方
DrJinsekharS
申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

DrJinu sekhars

post graduate department of Prasuti Tantra Evum shree roga Swaminarayan ayurvedic college Ahmedabad-mehsana Highway At And po saji Ta Kalol Dist

研究点 (1)

Loading locations...

相似试验